LAKE OSWEGO, Ore., Oct. 21, 2011 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:RXII), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D, President & CEO, will present a corporate update at the 10th Annual Biotechnology Industry Organization Investor Forum. The presentation will take place on Wednesday, October 26th, 2011 at 1:00 pm PDT at the Palace Hotel in San Francisco, CA.
